Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.4K Buy
510
+15
+3% +$555 ﹤0.01% 1670
2025
Q4
$20.8K Buy
495
+134
+37% +$5.4K ﹤0.01% 1547
2025
Q3
$12.4K Buy
+361
New +$10.4K ﹤0.01% 1600

Other funds holding VCYT

UMB Bank's VCYT Position: Q1 2026 in Review

UMB Bank increased its Veracyte (VCYT) stake by 3% in Q1 2026, buying an estimated $555 and bringing the position to 510 shares worth $16.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1670.

UMB Bank first reported a position in VCYT in Q3 2025 and has held it in 3 quarters since. The position peaked at $20.8K in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • UMB Bank held 510 shares of Veracyte worth $16.4K as of Q1 2026.
  • UMB Bank bought 15 Veracyte shares in Q1 2026, an estimated $555.
  • Veracyte made up ﹤0.01% of UMB Bank's portfolio in Q1 2026, its #1670 holding.
  • UMB Bank first reported a position in Veracyte in Q3 2025 and has held it in 3 quarters since.
  • UMB Bank's Veracyte position peaked at $20.8K in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on UMB Bank's 13F filing for Q1 2026, filed 11 May 2026.